Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20605355rdf:typepubmed:Citationlld:pubmed
pubmed-article:20605355lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:20605355lifeskim:mentionsumls-concept:C0007113lld:lifeskim
pubmed-article:20605355lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:20605355lifeskim:mentionsumls-concept:C1559154lld:lifeskim
pubmed-article:20605355lifeskim:mentionsumls-concept:C0123931lld:lifeskim
pubmed-article:20605355lifeskim:mentionsumls-concept:C0671970lld:lifeskim
pubmed-article:20605355lifeskim:mentionsumls-concept:C1517927lld:lifeskim
pubmed-article:20605355lifeskim:mentionsumls-concept:C0445204lld:lifeskim
pubmed-article:20605355lifeskim:mentionsumls-concept:C0282460lld:lifeskim
pubmed-article:20605355lifeskim:mentionsumls-concept:C1514888lld:lifeskim
pubmed-article:20605355lifeskim:mentionsumls-concept:C0205179lld:lifeskim
pubmed-article:20605355lifeskim:mentionsumls-concept:C0443252lld:lifeskim
pubmed-article:20605355pubmed:issue4lld:pubmed
pubmed-article:20605355pubmed:dateCreated2011-2-28lld:pubmed
pubmed-article:20605355pubmed:abstractTextPreoperative chemoradiotherapy (CRT) for locally advanced rectal cancer has shown benefit over postoperative CRT; however, a standard CRT regimen has yet to be defined. We performed a prospective concurrent CRT Phase II study with irinotecan and capecitabine in patients with locally advanced rectal cancer to investigate the efficacy and safety of this regimen.lld:pubmed
pubmed-article:20605355pubmed:languageenglld:pubmed
pubmed-article:20605355pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20605355pubmed:citationSubsetIMlld:pubmed
pubmed-article:20605355pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20605355pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20605355pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20605355pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20605355pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20605355pubmed:statusMEDLINElld:pubmed
pubmed-article:20605355pubmed:monthMarlld:pubmed
pubmed-article:20605355pubmed:issn1879-355Xlld:pubmed
pubmed-article:20605355pubmed:authorpubmed-author:ParkJae-GahbJ...lld:pubmed
pubmed-article:20605355pubmed:authorpubmed-author:KimDae-HyunDHlld:pubmed
pubmed-article:20605355pubmed:authorpubmed-author:JeongJun...lld:pubmed
pubmed-article:20605355pubmed:authorpubmed-author:ChangHee...lld:pubmed
pubmed-article:20605355pubmed:authorpubmed-author:KimDae YongDYlld:pubmed
pubmed-article:20605355pubmed:authorpubmed-author:JeongSeung-Yo...lld:pubmed
pubmed-article:20605355pubmed:authorpubmed-author:LimSeok-Byung...lld:pubmed
pubmed-article:20605355pubmed:authorpubmed-author:JungKyung...lld:pubmed
pubmed-article:20605355pubmed:authorpubmed-author:ChoiHyo...lld:pubmed
pubmed-article:20605355pubmed:authorpubmed-author:SohnDae...lld:pubmed
pubmed-article:20605355pubmed:authorpubmed-author:HongYong...lld:pubmed
pubmed-article:20605355pubmed:copyrightInfoCopyright © 2011 Elsevier Inc. All rights reserved.lld:pubmed
pubmed-article:20605355pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20605355pubmed:day15lld:pubmed
pubmed-article:20605355pubmed:volume79lld:pubmed
pubmed-article:20605355pubmed:ownerNLMlld:pubmed
pubmed-article:20605355pubmed:authorsCompleteYlld:pubmed
pubmed-article:20605355pubmed:pagination1171-8lld:pubmed
pubmed-article:20605355pubmed:meshHeadingpubmed-meshheading:20605355...lld:pubmed
pubmed-article:20605355pubmed:meshHeadingpubmed-meshheading:20605355...lld:pubmed
pubmed-article:20605355pubmed:meshHeadingpubmed-meshheading:20605355...lld:pubmed
pubmed-article:20605355pubmed:meshHeadingpubmed-meshheading:20605355...lld:pubmed
pubmed-article:20605355pubmed:meshHeadingpubmed-meshheading:20605355...lld:pubmed
pubmed-article:20605355pubmed:meshHeadingpubmed-meshheading:20605355...lld:pubmed
pubmed-article:20605355pubmed:meshHeadingpubmed-meshheading:20605355...lld:pubmed
pubmed-article:20605355pubmed:meshHeadingpubmed-meshheading:20605355...lld:pubmed
pubmed-article:20605355pubmed:meshHeadingpubmed-meshheading:20605355...lld:pubmed
pubmed-article:20605355pubmed:meshHeadingpubmed-meshheading:20605355...lld:pubmed
pubmed-article:20605355pubmed:meshHeadingpubmed-meshheading:20605355...lld:pubmed
pubmed-article:20605355pubmed:meshHeadingpubmed-meshheading:20605355...lld:pubmed
pubmed-article:20605355pubmed:meshHeadingpubmed-meshheading:20605355...lld:pubmed
pubmed-article:20605355pubmed:meshHeadingpubmed-meshheading:20605355...lld:pubmed
pubmed-article:20605355pubmed:meshHeadingpubmed-meshheading:20605355...lld:pubmed
pubmed-article:20605355pubmed:meshHeadingpubmed-meshheading:20605355...lld:pubmed
pubmed-article:20605355pubmed:meshHeadingpubmed-meshheading:20605355...lld:pubmed
pubmed-article:20605355pubmed:meshHeadingpubmed-meshheading:20605355...lld:pubmed
pubmed-article:20605355pubmed:year2011lld:pubmed
pubmed-article:20605355pubmed:articleTitlePreoperative chemoradiation with irinotecan and capecitabine in patients with locally advanced resectable rectal cancer: long-term results of a Phase II study.lld:pubmed
pubmed-article:20605355pubmed:affiliationCenter for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang, South Korea.lld:pubmed
pubmed-article:20605355pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20605355pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:20605355pubmed:publicationTypeClinical Trial, Phase IIlld:pubmed